Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
NJ Bio, Inc. logo — Integrated Chemistry Solution Provider

NJ Bio, Inc.

Integrated Chemistry Solution Provider

Founded 2019 United States Princeton, United States 148 employees Acquired Total: $70.00M Biotechnology

General Information

Company Name NJ Bio, Inc.
Founded Year 2019
Location United States Princeton, United States
Employees 148
Industries Biotechnology
Funding Stage Acquired
Business Model B2B
Revenue Model Service Fee, Project Based
Social

BounceWatch is an independent company data service, not affiliated with NJ Bio, Inc.. To contact NJ Bio, Inc., visit njbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NJ Bio, Inc. compare?

A PDF of NJ Bio, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NJ Bio, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NJ Bio, Inc.

NJ Bio, Inc., founded in 2019, stands out as a leading CRO (Contract Research Organization) in the biotechnology industry. Known for its tagline, "Integrated Chemistry Solution Provider," the company is dedicated to delivering comprehensive chemistry and biology services. Its expertise spans key areas such as antibody drug conjugates, nucleotide and oligonucleotide synthesis, multi-step organic synthesis, PROTAC, and flow chemistry-based process development.

Headquartered in Princeton, New Jersey, with additional facilities in Bristol, PA, NJ Bio also has a subsidiary in Mumbai, India, enhancing its global service capabilities. The company's robust service portfolio is crafted to cater to the complex needs of clients from biotech and pharma sectors.

Recently, NJ Bio received a significant investment of $64.40M on 01 December 2024, facilitated by OSI Pharmaceuticals. This capital influx is poised to propel further innovation and expansion, marking a promising horizon for potential investors.

Business keywords: Integrated Chemistry Solutions, Biology Services, Antibody Drug Conjugates, Nucleotide Synthesis, Oligonucleotide Synthesis, Multi-step Organic Synthesis, PROTAC, Flow Chemistry, Process Development, Custom Synthesis, Protein Purification, Medicinal Chemistry, Bioconjugation, Small Molecule Development, Biopharmaceuticals

Services & Products

ADC Services
Manufacturing Services
Payloads and Linkers Development
Custom Synthesis
Medicinal Chemistry Services
BioNMR for Drug Discovery

Target Customers

Biopharmaceutical Companies Early-Stage Biotech Companies Antibody Research Companies ADC Platform Companies Large Biotech Companies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $64.40M 1
OSI Pharmaceuticals
OSI Pharmaceuticals
01 Dec 2024
Early VC $5.60M -
01 Mar 2023

NJ Bio, Inc. Alternatives & Competitors

View All Alternatives
NJ Bio, Inc. vs
Apex Molecular Ltd
Apex Molecular Ltd United Kingdom

Providing specialist chemistry synthesis services to the Life Science industry

Debt Financing
7 employees
Biotechnology, Health Care
NJ Bio, Inc. vs
Tenova Pharma
Tenova Pharma United States

Chemical and Biochemical Reagents | Custom Chemical Synthesis | Medicinal Chemistry Services

5 employees
Biotechnology, Life Sciences
NJ Bio, Inc. vs
PepLib
PepLib China

Rethink Peptide Drug Discovery: Universal-Exact-Diverse

Series A
6 employees
Biotechnology, Health Care
View all alternatives

FAQ About NJ Bio, Inc.

Integrated Chemistry Solution Provider
NJ Bio, Inc. was founded in 2019.
NJ Bio, Inc. is headquartered in Princeton, United States.
NJ Bio, Inc. operates in Biotechnology. Its work centres on Integrated Chemistry Solutions, Biology Services, Antibody Drug Conjugates and Nucleotide Synthesis. Its customers include Biopharmaceutical Companies, Early-Stage Biotech Companies and Antibody Research Companies.
NJ Bio, Inc. has a B2B business model. Its revenue comes from Service Fee and Project Based.
NJ Bio, Inc. has approximately 148 employees.
NJ Bio, Inc. has completed 2 funding rounds, raising a total of $70.00M. The latest funding stage is Acquired.
NJ Bio, Inc. offers: ADC Services, Manufacturing Services, Payloads and Linkers Development, Custom Synthesis, Medicinal Chemistry Services, BioNMR for Drug Discovery.
Top alternatives and competitors to NJ Bio, Inc. include Apex Molecular Ltd, Tenova Pharma, PepLib . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NJ Bio, Inc. and Apex Molecular Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NJ Bio, Inc., https://bouncewatch.com/company/nj-bio-inc, updated 26 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout